Michael D. West
2018 - Serina Therapeutics
In 2018, Michael D. West earned a total compensation of $1.7M as Chief Executive Officer at Serina Therapeutics, a 45% increase compared to previous year.
Compensation breakdown
| Bonus | $39,000 |
|---|---|
| Option Awards | $1,025,497 |
| Salary | $575,433 |
| Other | $10,477 |
| Total | $1,650,407 |
West received $1M in option awards, accounting for 62% of the total pay in 2018.
West also received $39K in bonus, $575.4K in salary and $10.5K in other compensation.
Rankings
In 2018, Michael D. West's compensation ranked 6,702nd out of 14,244 executives tracked by ExecPay. In other words, West earned more than 52.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,702 out of 14,244 | 53rd |
Division Manufacturing | 2,556 out of 5,765 | 56th |
Major group Chemicals And Allied Products | 959 out of 2,128 | 55th |
Industry group Drugs | 804 out of 1,817 | 56th |
Industry Pharmaceutical Preparations | 627 out of 1,391 | 55th |
Source: SEC filing on November 29, 2019.
West's colleagues
We found three more compensation records of executives who worked with Michael D. West at Serina Therapeutics in 2018.
News
Serina Therapeutics CEO Michael West's 2020 pay falls 46% to $561K
November 24, 2021
Serina Therapeutics CEO Michael West's 2019 pay falls 24% to $1M
November 24, 2020
Serina Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
November 29, 2019
BioTime CEO Brian Culley's 2018 pay jumps 75% to $2.8M
June 14, 2019